Suchergebnisse - "Altmann, Bettina"

PubPharm (34)

1

Radiotherapy in younger patients with advanced aggressive B-cell lymphoma-long-term results from the phase 3 R-MegaCHOEP trial

enthalten in: Leukemia | 2024

von Oertel, M. | Ziepert, M. | Frontzek, F. | +9

2

Impact of vincristine dose reduction on outcomes of patients with aggressive B-cell lymphoma treated with (R)-CHOP

enthalten in: Haematologica | 2023

von Bewarder, M. | Kaddu-Mulindwa, D. | Kos, I. | +12

3

Central nervous system relapse in younger patients with diffuse large B-cell lymphoma : a LYSA and GLA/DSHNHL analysis

enthalten in: Blood advances | 2023

von Thieblemont, C. | Altmann, B. | Frontzek, F. | +19

4

Radiation and Dose-densification of R-CHOP in Primary Mediastinal B-cell Lymphoma : Subgroup Analysis of the UNFOLDER Trial

enthalten in: HemaSphere | 2023

von Held, G. | Thurner, L. | Poeschel, V. | +30

5

Radiation and Dose-densification of R-CHOP in Aggressive B-cell Lymphoma With Intermediate Prognosis : The UNFOLDER Study

enthalten in: HemaSphere | 2023

von Thurner, L. | Ziepert, M. | Berdel, C. | +44

6

Radiation and dose-densification of R-CHOP in primary mediastinal B-cell lymphoma : subgroup analysis of the UNFOLDER trial

enthalten in: HemaSphere | July 2023

von Held, G. | Thurner, L. | Poeschel, V. | +30

7

First-line Treatment With Bendamustine and Rituximab for Old and Frail Patients With Aggressive Lymphoma : Results of the B-R-ENDA Trial

enthalten in: HemaSphere | 2022

von Braulke, F. | Zettl, F. | Ziepert, M. | +18

8

First-line treatment with bendamustine and rituximab for old and frail patients with aggressive lymphoma : results of the B-R-ENDA trial

enthalten in: HemaSphere | Dec 1, 2022

von Braulke, F. | Zettl, F. | Ziepert, M. | +18

9

Central nervous system relapse in younger patients with diffuse large B-cell lymphoma - a LYSA and GLA/ DSHNHL analysis

enthalten in: ResearchSquare.com | 2022

von Thieblemont, C. | Altmann, B. | Frontzek, F. | +19

10

Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma

enthalten in: HemaSphere | 2022

von Houot, R. | Poeschel, V. | Altmann, B. | +26